Skip to main content
Log in

A Heterogeneously Structured Composite Based on Poly(lactic-co-glycolic acid) Microspheres and Poly(vinyl alcohol) Hydrogel Nanoparticles for Long-Term Protein Drug Delivery

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To prepare a heterogeneously structured composite based on poly (lactic-co-glycolic acid) (PLGA) microspheres and poly(vinyl alcohol) (PVA) hydrogel nanoparticles for long-term protein drug delivery.

Methods. A heterogeneously structured composite in the form of PLGA microspheres containing PVA nanoparticles was prepared and named as PLGA-PVA composite microspheres. A model protein drug, bovine serum albumin (BSA), was encapsulated in the PVA nanoparticles first. The BSA-containing PVA nanoparticles was then loaded in the PLGA microspheres by using a phase separation method. The protein-containing PLGA-PVA composite microspheres were characterized with regard to morphology, size and size distribution, BSA loading efficiency, in vitroBSA release, and BSA stability.

Results. The protein-containing PLGA-PVA composite microspheres possessed spherical shape and nonporous surface. The PLGA-PVA composite microspheres had normal or Gaussian size distribution. The particle size ranged from 71.5 μm to 282.7 μm. The average diameter of the composite microspheres was 180 μm. The PLGA-PVA composite microspheres could release the protein (BSA) for two months. The protein stability study showed that BSA was protected during the composite microsphere preparation and stabilized inside the PLGA-PVA composite microspheres.

Conclusions. The protein-containing PLGA-PVA composite may be suitable for long-term protein drug delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. X. S. Wu. Preparation, characterization, and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In D. L. Wise, D. J. Trantolo, D. E. Altobeli, M. J. Yaszemski, J. D. Gresser, and E. R. Schwartz (eds.), Encyclopedic Handbook of Biomaterials and Bioengineering, Part A: Materials, Vol. II., Dekker, New York, 1995, pp. 1151-1152.

    Google Scholar 

  2. R. Jalil and J. R. Nixon. Biodegradable poly(lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsulation 7:297-325 (1990).

    Google Scholar 

  3. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8:713-720 (1991).

    Google Scholar 

  4. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, and T. A. Shimamoto. New technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 36:1095-1103 (1988).

    Google Scholar 

  5. H. Okada and Y. Ogawa. Prolonged release microcapsule. U.S. patent 5,476,663 (1995).

  6. H. Okada, Y. Inoue, and Y. Ogawa. Prolonged release microcapsules. U.S. patent 5,480,656 (1996).

  7. W. Lu and T. G. Park. Protein release from poly(lactic-co-glycolic acid) microspheres: Protein stability problems. PDA J. Pharm. Sci. Tech. 49:13-19 (1995).

    Google Scholar 

  8. T. Uchida, A. Yagi, Y. Oda, Y. Dakada, and S. Goto. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 44:235-236 (1996).

    Google Scholar 

  9. K. J. Zhu, X. Lin, and S. Yang. Preparation and properties of D,L-lactide and ethylene oxide copolymer: A modifying biodegradable polymeric material. J. Polym. Sci.: Part C: Polymer Letters. 24:331-337 (1986).

    Google Scholar 

  10. D. Cohn, H. Younes, and G. Marom. Amorphous and crystalline morphologies in glycolic acid and lactic acid polymers. Polymer. 28:18-22 (1987).

    Google Scholar 

  11. H. M. Dollinger and S. P. Sawan. Bicontinuous controlled-release matrices composed of poly(d,1-lactic acid) blended with ethylenevinyl acetate copolymer. Polym. Prepr. 31:211-212 (1990).

    Google Scholar 

  12. T. Kissel, Z. Brich, S. Bantle, I. Lancranjan, F. Nimmerfall, and P. Vit. Parenteral depot-systems on the basis of biodegradable polyesters. J. Contr. Rel. 16:27-42 (1991).

    Google Scholar 

  13. T. G. Park, S. Cohen, and R. Langer. Poly(L-lactic acid)/Pluronic Blends: Characterization of phase separation behavior, degradation, and morphology and use as protein-release matrices. Macromol. 25:116-122 (1992).

    Google Scholar 

  14. C. G. Pitt, Y. Cha, S. S. Shah, and K. J. Zhu. Blends of PVA and PGLA: control of the permeability and degradability of hydrogels by blending. J. Contr. Rel. 19:189-200 (1992).

    Google Scholar 

  15. J. K. Li, N. Wang, and X. S. Wu. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. J. Pharm. Sci. 86:891-895 (1997).

    Google Scholar 

  16. N. Wang and X. S. Wu. A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel. Int. J. Pharm. 166:1-14 (1998).

    Google Scholar 

  17. J. K. Li, N. Wang, and X. S. Wu. Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein drug delivery. J. Contr. Rel. 56:117-126 (1998).

    Google Scholar 

  18. M. C. Julienne, M. J. Alonso, J. L. Gómez Amoza, and J. P. Benoit. Preparation of poly(D,L-lactide/glycolide) nanoparticles of controlled particle size distribution: application of experimental designs. Drug Dev. Ind. Pharm. 18:1063-1077 (1992).

    Google Scholar 

  19. T. Uchida, S. Goto, and T. P. Foster. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation. J. Pharm. Pharmacol. 47:556-560 (1994).

    Google Scholar 

  20. G. A. Brazeau, M. Sciame, S. A. Al-Suwayeh, and E. Fattal. Evaluation of PLGA microspheres size effect on myotoxicity using the isolated rodent skeletal muscle model. Pharm. Dev. Tech. 1:279-283 (1996).

    Google Scholar 

  21. L. M. Sanders, J. S. Kent, G. I. Mcrae, B. H. Vickery, T. R. Tice, and D. H. Lewis. Controlled release of leutinizing hormone releasing hormone analogue from poly (d,l-lactide-co-glycolide) microspheres. J. Pharm. Sci. 73:1294-1297 (1984).

    Google Scholar 

  22. C. N. Pace. Conformational stability of globular proteins. Trends in Biochem. Sci. 15:14-17 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xue Shen Wu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, N., Wu, X.S. & Li, J.K. A Heterogeneously Structured Composite Based on Poly(lactic-co-glycolic acid) Microspheres and Poly(vinyl alcohol) Hydrogel Nanoparticles for Long-Term Protein Drug Delivery. Pharm Res 16, 1430–1435 (1999). https://doi.org/10.1023/A:1018911411381

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018911411381

Navigation